Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics and clopidogrel response in patients undergoing percutaneous coronary interventions.

Clinical pharmacology and therapeutics - 1 Mar 2011

Beitelshees A L, Horenstein R B, Vesely M R, Mehra M R, Shuldiner A R

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angina Pectoris
Share to Angioplasty, Balloon, Coronary
Share to Aryl Hydrocarbon Hydroxylases
Share to Clopidogrel

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C19

Share to Exercise Test

Share to Platelet Aggregation Inhibitors

Share to Ticlopidine

Source

Open in PubMed Open full text

Identifiers

PMID: 21270785
DOI: 10.1038/clpt.2010.316
PMCID: PMC3235907

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics and clopidogrel response in patients undergoing percutaneous coronary interventions.PMID 21270785Read ↗

Pharmacogenetics of Clopidogrel: An Unresolved Issue.Semantic proximity Read ↗

Current controversies in the pharmacogenomics of clopidogrel.Semantic proximity Read ↗

Cytochrome p-450 polymorphisms and response to clopidogrel.Semantic proximity Read ↗

Individual variability in the disposition of and response to clopidogrel: Pharmacogenomics and beyondSemantic proximity Read ↗

Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points—Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)Semantic proximity Read ↗

Clopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?Semantic proximity Read ↗

Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention.Semantic proximity Read ↗

Clopidogrel in acute coronary syndrome: to genotype or not?Semantic proximity Read ↗

Clopidogrel and Genotyping.Semantic proximity Read ↗

Pharmacogenetics of antiplatelet therapy.Semantic proximity Read ↗

Clopidogrel pharmacogenetics: Beyond candidate genes and genome-wide association studies.Semantic proximity Read ↗

Cardiovascular drugs and the genetic response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.